Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Army
AstraZeneca
Healthtrust
Boehringer Ingelheim
Chinese Patent Office
Daiichi Sankyo
Moodys
Julphar

Generated: December 19, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MAXALT-MLT

« Back to Dashboard

Clinical Trials for Maxalt-mlt

Trial ID Title Status Sponsor Phase Summary
NCT00360282 Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines? Completed Merck Sharp & Dohme Corp. N/A The purpose of this study is to determine if Rizatriptan, a migraine medication, lowers motion sickness in migraine sufferers.
NCT00360282 Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines? Completed University of Pittsburgh N/A The purpose of this study is to determine if Rizatriptan, a migraine medication, lowers motion sickness in migraine sufferers.
NCT00397254 Two Rizatriptan Prescribing Portions for Treatment of Migraine Completed Merck Sharp & Dohme Corp. Phase 4 The primary objective of this study is to evaluate a clinical limit (CL) of rizatriptan (9 rizatriptan 10mg Orally Disintegrating Tablet (ODT) per month) versus (vs.) a formulary limit (FL) of rizatriptan (27 rizatriptan 10mg ODT per month) as measured by the number of days of migraine per month.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Maxalt-mlt

Condition Name

Condition Name for Maxalt-mlt
Intervention Trials
Migraine 2
Migraine Without Aura 1
Migraine With Aura 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Maxalt-mlt
Intervention Trials
Migraine Disorders 5
Headache 2
Motion Sickness 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Maxalt-mlt

Trials by Country

Trials by Country for Maxalt-mlt
Location Trials
United States 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Maxalt-mlt
Location Trials
California 2
Pennsylvania 2
Minnesota 1
Washington 1
Illinois 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Maxalt-mlt

Clinical Trial Phase

Clinical Trial Phase for Maxalt-mlt
Clinical Trial Phase Trials
Phase 4 1
Phase 3 2
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Maxalt-mlt
Clinical Trial Phase Trials
Completed 4
Recruiting 1
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Maxalt-mlt

Sponsor Name

Sponsor Name for Maxalt-mlt
Sponsor Trials
Merck Sharp & Dohme Corp. 5
Clinvest 1
University of Pittsburgh 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Maxalt-mlt
Sponsor Trials
Other 5
Industry 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Covington
Mallinckrodt
Medtronic
McKinsey
Harvard Business School
Accenture
Cantor Fitzgerald
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.